Request for Covid-19 Impact Assessment of this Report

Healthcare

Covid-19 Impact on Tizanidine Market , Global Research Reports 2020-2021

  • BMR3851441
  • 96 Pages
  • May 2020
  • Healthcare
Download Sample    Get Discount   
 
Tizanidine (trade names Zanaflex (Acorda Therapeutics), Sirdalud (Novartis), Relentus (Beximco Pharma)) is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia.

This report provides a complete quantitative data and qualitative analysis on the global market for Tizanidine. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.

Prior to COVID-19, the global market for Tizanidine was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Tizanidine is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.

This report covers market size and forecasts of Tizanidine, including the following market information:

Global Tizanidine Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Tizanidine Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Tizanidine Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Tizanidine Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players

Major competitors identified in this market include Actavis, Teva, Sandoz, Acorda, Unichem Laboratories, APOTEX, Sun Pharmaceutical, CorePharma, Dr. Reddy's Laboratories, Mylan, Oxford PharmaGenesis, Niche Generics Limited, CREDIT PHARMA, YABANG, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Based on the Type:

2mg Tablet

4mg Tablet

2mg Capsules

4mg Capsules

6mg Capsules

Based on the Application:

Kids

Adults

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Tizanidine Industry

1.7 COVID-19 Impact: Tizanidine Market Trends

2 Global Tizanidine Quarterly Market Size Analysis

2.1 Tizanidine Business Impact Assessment - COVID-19

2.1.1 Global Tizanidine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Tizanidine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Tizanidine Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Tizanidine Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Tizanidine Factory Price by Manufacturers

3.3 Location of Key Manufacturers Tizanidine Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Tizanidine Market

3.5 Key Manufacturers Tizanidine Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Tizanidine Segments, By Type

4.1 Introduction

1.4.1 2mg Tablet

1.4.2 4mg Tablet

1.4.3 2mg Capsules

1.4.4 4mg Capsules

1.4.5 6mg Capsules

4.2 By Type, Global Tizanidine Market Size, 2019-2021

4.2.1 By Type, Global Tizanidine Market Size by Type, 2020-2021

4.2.2 By Type, Global Tizanidine Price, 2020-2021

5 Impact of Covid-19 on Tizanidine Segments, By Application

5.1 Overview

5.5.1 Kids

5.5.2 Adults

5.2 By Application, Global Tizanidine Market Size, 2019-2021

5.2.1 By Application, Global Tizanidine Market Size by Application, 2019-2021

5.2.2 By Application, Global Tizanidine Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Actavis

7.1.1 Actavis Business Overview

7.1.2 Actavis Tizanidine Quarterly Production and Revenue, 2020

7.1.3 Actavis Tizanidine Product Introduction

7.1.4 Actavis Response to COVID-19 and Related Developments

7.2 Teva

7.2.1 Teva Business Overview

7.2.2 Teva Tizanidine Quarterly Production and Revenue, 2020

7.2.3 Teva Tizanidine Product Introduction

7.2.4 Teva Response to COVID-19 and Related Developments

7.3 Sandoz

7.3.1 Sandoz Business Overview

7.3.2 Sandoz Tizanidine Quarterly Production and Revenue, 2020

7.3.3 Sandoz Tizanidine Product Introduction

7.3.4 Sandoz Response to COVID-19 and Related Developments

7.4 Acorda

7.4.1 Acorda Business Overview

7.4.2 Acorda Tizanidine Quarterly Production and Revenue, 2020

7.4.3 Acorda Tizanidine Product Introduction

7.4.4 Acorda Response to COVID-19 and Related Developments

7.5 Unichem Laboratories

7.5.1 Unichem Laboratories Business Overview

7.5.2 Unichem Laboratories Tizanidine Quarterly Production and Revenue, 2020

7.5.3 Unichem Laboratories Tizanidine Product Introduction

7.5.4 Unichem Laboratories Response to COVID-19 and Related Developments

7.6 APOTEX

7.6.1 APOTEX Business Overview

7.6.2 APOTEX Tizanidine Quarterly Production and Revenue, 2020

7.6.3 APOTEX Tizanidine Product Introduction

7.6.4 APOTEX Response to COVID-19 and Related Developments

7.7 Sun Pharmaceutical

7.7.1 Sun Pharmaceutical Business Overview

7.7.2 Sun Pharmaceutical Tizanidine Quarterly Production and Revenue, 2020

7.7.3 Sun Pharmaceutical Tizanidine Product Introduction

7.7.4 Sun Pharmaceutical Response to COVID-19 and Related Developments

7.8 CorePharma

7.8.1 CorePharma Business Overview

7.8.2 CorePharma Tizanidine Quarterly Production and Revenue, 2020

7.8.3 CorePharma Tizanidine Product Introduction

7.8.4 CorePharma Response to COVID-19 and Related Developments

7.9 Dr. Reddy's Laboratories

7.9.1 Dr. Reddy's Laboratories Business Overview

7.9.2 Dr. Reddy's Laboratories Tizanidine Quarterly Production and Revenue, 2020

7.9.3 Dr. Reddy's Laboratories Tizanidine Product Introduction

7.9.4 Dr. Reddy's Laboratories Response to COVID-19 and Related Developments

7.10 Mylan

7.10.1 Mylan Business Overview

7.10.2 Mylan Tizanidine Quarterly Production and Revenue, 2020

7.10.3 Mylan Tizanidine Product Introduction

7.10.4 Mylan Response to COVID-19 and Related Developments

7.11 Oxford PharmaGenesis

7.11.1 Oxford PharmaGenesis Business Overview

7.11.2 Oxford PharmaGenesis Tizanidine Quarterly Production and Revenue, 2020

7.11.3 Oxford PharmaGenesis Tizanidine Product Introduction

7.11.4 Oxford PharmaGenesis Response to COVID-19 and Related Developments

7.12 Niche Generics Limited

7.12.1 Niche Generics Limited Business Overview

7.12.2 Niche Generics Limited Tizanidine Quarterly Production and Revenue, 2020

7.12.3 Niche Generics Limited Tizanidine Product Introduction

7.12.4 Niche Generics Limited Response to COVID-19 and Related Developments

7.13 CREDIT PHARMA

7.13.1 CREDIT PHARMA Business Overview

7.13.2 CREDIT PHARMA Tizanidine Quarterly Production and Revenue, 2020

7.13.3 CREDIT PHARMA Tizanidine Product Introduction

7.13.4 CREDIT PHARMA Response to COVID-19 and Related Developments

7.14 YABANG

7.14.1 YABANG Business Overview

7.14.2 YABANG Tizanidine Quarterly Production and Revenue, 2020

7.14.3 YABANG Tizanidine Product Introduction

7.14.4 YABANG Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Tizanidine Supply Chain Analysis

8.1.1 Tizanidine Supply Chain Analysis

8.1.2 Covid-19 Impact on Tizanidine Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Tizanidine Distribution Channels

8.2.2 Covid-19 Impact on Tizanidine Distribution Channels

8.2.3 Tizanidine Distributors

8.3 Tizanidine Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Tizanidine Assessment

Table 9. COVID-19 Impact: Tizanidine Market Trends

Table 10. COVID-19 Impact Global Tizanidine Market Size

Table 11. Global Tizanidine Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Tizanidine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Tizanidine Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Tizanidine Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Tizanidine Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Tizanidine Market Growth Drivers

Table 17. Global Tizanidine Market Restraints

Table 18. Global Tizanidine Market Opportunities

Table 19. Global Tizanidine Market Challenges

Table 20. Key Manufacturers Tizanidine Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Tizanidine Market Size, 2019 (K Units) & (US$ Million)

Table 22. Tizanidine Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Tizanidine Manufacturing Plants

Table 24. Key Manufacturers Tizanidine Market Served

Table 25. Date of Key Manufacturers Enter into Tizanidine Market

Table 26. Key Manufacturers Tizanidine Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Tizanidine Market Size by Type, 2020, (US$ Million)

Table 29. Global Tizanidine Market Size by Type, 2020 (K Units)

Table 30. Global Tizanidine Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Tizanidine Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Tizanidine Market Size by Application, 2020-2021 (K Units)

Table 33. Global Tizanidine Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Tizanidine Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Tizanidine Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Tizanidine Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Tizanidine Market Size, 2019-2021 (K Units)

Table 38. US Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Tizanidine Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Tizanidine Market Size, 2019-2021 (K Units)

Table 43. Germany Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Tizanidine Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Tizanidine Market Size, 2019-2021 (K Units)

Table 50. China Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Tizanidine Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Actavis Business Overview

Table 58. Actavis Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Actavis Tizanidine Product

Table 60. Actavis Response to COVID-19 and Related Developments

Table 61. Teva Business Overview

Table 62. Teva Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Teva Tizanidine Product

Table 64. Teva Response to COVID-19 and Related Developments

Table 65. Sandoz Business Overview

Table 66. Sandoz Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Sandoz Tizanidine Product

Table 68. Sandoz Response to COVID-19 and Related Developments

Table 69. Acorda Business Overview

Table 70. Acorda Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Acorda Tizanidine Product

Table 72. Acorda Response to COVID-19 and Related Developments

Table 73. Unichem Laboratories Business Overview

Table 74. Unichem Laboratories Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Unichem Laboratories Tizanidine Product

Table 76. Unichem Laboratories Response to COVID-19 and Related Developments

Table 77. APOTEX Business Overview

Table 78. APOTEX Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. APOTEX Tizanidine Product

Table 80. APOTEX Response to COVID-19 and Related Developments

Table 81. Sun Pharmaceutical Business Overview

Table 82. Sun Pharmaceutical Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Sun Pharmaceutical Tizanidine Product

Table 84. Sun Pharmaceutical Response to COVID-19 and Related Developments

Table 85. CorePharma Business Overview

Table 86. CorePharma Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. CorePharma Tizanidine Product

Table 88. CorePharma Response to COVID-19 and Related Developments

Table 89. Dr. Reddy's Laboratories Business Overview

Table 90. Dr. Reddy's Laboratories Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Dr. Reddy's Laboratories Tizanidine Product

Table 92. Dr. Reddy's Laboratories Response to COVID-19 and Related Developments

Table 93. Mylan Business Overview

Table 94. Mylan Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Mylan Tizanidine Product

Table 96. Mylan Response to COVID-19 and Related Developments

Table 97. Oxford PharmaGenesis Business Overview

Table 98. Oxford PharmaGenesis Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Oxford PharmaGenesis Tizanidine Product

Table 100. Oxford PharmaGenesis Response to COVID-19 and Related Developments

Table 101. Niche Generics Limited Business Overview

Table 102. Niche Generics Limited Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Niche Generics Limited Tizanidine Product

Table 104. Niche Generics Limited Response to COVID-19 and Related Developments

Table 105. CREDIT PHARMA Business Overview

Table 106. CREDIT PHARMA Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. CREDIT PHARMA Tizanidine Product

Table 108. CREDIT PHARMA Response to COVID-19 and Related Developments

Table 109. YABANG Business Overview

Table 110. YABANG Tizanidine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. YABANG Tizanidine Product

Table 112. YABANG Response to COVID-19 and Related Developments

Table 113. Tizanidine Distributors List

Table 114. Tizanidine Customers List

Table 115. Covid-19 Impact on Tizanidine Customers

List of Figures

Figure 1. Tizanidine Product Picture

Figure 2. Tizanidine Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Tizanidine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Tizanidine Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Tizanidine Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Tizanidine Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Tizanidine Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Tizanidine Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Tizanidine Market Size Market Share, 2019-2021

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950